Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
BMC Anesthesiol ; 22(1): 387, 2022 12 13.
Artículo en Inglés | MEDLINE | ID: covidwho-2162295

RESUMEN

BACKGROUND: We hypothesized that the measured expiratory time constant (TauE) could be a bedside parameter for the evaluation of positive end-expiratory pressure (PEEP) settings in mechanically ventilated COVID-19 patients during pressure-controlled ventilation (PCV). METHODS: A prospective study was conducted including consecutively admitted adults (n = 16) with COVID-19-related ARDS requiring mechanical ventilation. A PEEP titration using PCV with a fixed driving pressure of 14 cmH2O was performed and TauE recorded at each PEEP level (0 to 18 cmH2O) in prone (n = 29) or supine (n = 24) positions. The PEEP setting with the highest TauE (TauEMAX) was considered to represent the best tradeoff between recruitment and overdistention. RESULTS: Two groups of patterns were observed in the TauE plots: recruitable (R) (75%) and nonrecruitable (NR) (25%). In the R group, the optimal PEEP and PEEP ranges were 8 ± 3 cmH2O and 6-10 cmH2O for the prone position and 9 ± 3 cmH2O and 7-12 cmH2O for the supine position. In the NR group, the optimal PEEP and PEEP ranges were 4 ± 4 cmH2O and 1-8 cmH2O for the prone position and 5 ± 3 cmH2O and 1-7 cmH2O for the supine position, respectively. The R group showed significantly higher optimal PEEP (p < 0.004) and PEEP ranges (p < 0.001) than the NR group. Forty-five percent of measurements resulted in the most optimal PEEP being significantly different between the positions (p < 0.01). Moderate positive correlation has been found between TauE vs CRS at all PEEP levels (r2 = 0.43, p < 0.001). CONCLUSIONS: TauE may be a novel method to assess PEEP levels. There was wide variation in patient responses to PEEP, which indicates the need for personalized evaluation.


Asunto(s)
COVID-19 , Síndrome de Dificultad Respiratoria , Adulto , Humanos , Respiración con Presión Positiva/métodos , Respiración Artificial/métodos , Síndrome de Dificultad Respiratoria/terapia , Estudios Prospectivos , Estudios de Factibilidad , COVID-19/terapia
2.
J Int Med Res ; 50(5): 3000605221101970, 2022 May.
Artículo en Inglés | MEDLINE | ID: covidwho-1874963

RESUMEN

OBJECTIVE: We evaluated pressure-controlled ventilation (PCV) with multiple programmed levels of positive end expiratory pressure (programmed multi-level ventilation; PMLV) in patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). METHODS: We conducted a multicenter, retrospective study from November 2020 to February 2021. PMLV was used with PCV in all patients with intensive care admission until improvement in oxygenation (fraction of inspired oxygen [FiO2] ≤0.50 and oxygen saturation [SpO2] >92%). The observed outcomes were improvement of hypoxemia, length of mechanical ventilation, partial pressure of carbon dioxide (PaCO2) stability, and adverse events. RESULTS: Of 188 mechanically ventilated patients with COVID-19-related ARDS, we analyzed 60 patients treated with PMLV. Hypoxemia improved in 55 (92%) patients, as measured by the change in partial pressure of oxygen/FiO2 and SpO2/FiO2 ratios on day 3 versus day 1, and in 32 (66%) ventilated patients on day 7 versus day 3. The median (interquartile range) length of mechanical ventilation for survivors and non-survivors was 8.4 (4.7-14.9) and 6.7 (3.6-10.3) days, respectively. CONCLUSIONS: PMLV appears to be a safe and effective ventilation strategy for improving hypoxemia in patients with COVID-19-related ARDS. Further studies are needed comparing the PMLV mode with the conventional ARDS ventilatory approach.


Asunto(s)
COVID-19 , Síndrome de Dificultad Respiratoria , COVID-19/complicaciones , COVID-19/terapia , Humanos , Hipoxia/etiología , Hipoxia/terapia , Oxígeno , Síndrome de Dificultad Respiratoria/etiología , Síndrome de Dificultad Respiratoria/terapia , Estudios Retrospectivos
3.
Intensive Care Medicine Experimental ; 10(1), 2022.
Artículo en Inglés | ProQuest Central | ID: covidwho-1837246

RESUMEN

Positive end-expiratory pressure (PEEP) has been an important component of mechanical ventilation for over 50 years, yet PEEP selection remains highly debatable in the critical care community. Despite numerous studies trying to answer the ‘PEEP question’, there are often conflicting opinions when it comes to recommendations based on clinical trials [1]. Tree major studies (ALVEOLI, LOVS, EXPRESS) assessing higher versus lower PEEP in combination with low tidal volume (Vt) for acute respiratory distress syndrome (ARDS) failed to show decrease in mortality, although a meta-analysis of the three trials suggested a survival benefit for a subgroup of patients with severe ARDS [2]. It is universally accepted that higher PEEP may be helpful in ARDS patients where recruitability is expected but proves harmful in other groups of patients contributing to ventilation induced lung injury (VILI). Therefore, as many authors have suggested that not only one PEEP does not fit all, but also looking for the ‘best’ PEEP has little meaning because within mechanical power, it is just one part of the whole [3]. Since the introduction of PEEP into clinical practice, researchers have been focusing on finding the single most suitable PEEP that usually corresponded to best lung mechanics (i.e., highest compliance of the respiratory system) or oxygenation. However, we would like to challenge this idea and introduce another approach to PEEP research in critically ill lungs. We hypothesize, that patients with nonhomogeneous lungs could be supported on mechanical ventilation using multiple and alternating levels of PEEP. In the following paragraphs, we will list and elaborate on several reasons supporting our hypothesis of potential benefits of using multiple alternating PEEP levels.

4.
Intensive Care Med Exp ; 10(1): 9, 2022 Mar 21.
Artículo en Inglés | MEDLINE | ID: covidwho-1756421
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA